Feature|Articles|February 15, 2024
- Pharmaceutical Executive: February 2024
- Volume 44
- Issue 1
Pharmaceutical Executive: February 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive February 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 2 years ago
Central to the Missionabout 2 years ago
Two Frameworks for Orphan Drug IDN Launch Planningabout 2 years ago
Sustainability and Progress Continue to Make Headlines in 2024about 2 years ago
Building Resiliency: Essential Leadership Principles for 2024about 2 years ago
Will Strong Early-Year Vibes Translate to More Stabilization Ahead?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
5

